Bako Diagnostics and StrataDx Announce a Strategic Relationship. The Parent Company of Bako Diagnostics, the Leading U.S. Podiatry-focused Pathology
Laboratory, has Acquired StrataDx, a Leading Laboratory Focused on Dermatopathology and Oral Pathology
ATLANTA/BOSTON—October 10, 2018— Bako Diagnostics and StrataDx announce a strategic relationship. The parent company of Bako Diagnostics has acquired
StrataDx, a leading U.S. dermatopathology and oral pathology laboratory, serving physicians across the U.S.
While maintaining separate clinical laboratories, the common ownership allows the companies to operate more efficiently and bring their respective core services to broader markets,
while continuing to serve their customers independently.
“We are pleased to join with Bako Diagnostics in this strategic relationship,” stated Lisa Cohen, MD, CEO of StrataDx. “We will continue to provide our customers with the same
high quality dermatopathology, oral pathology, surgical pathology and clinical services they have come to expect without interruption. We also look forward to heightening
our focus on the dermatology market while expanding our customer base.” Dr. Lisa Cohen will continue to lead the group at StrataDx and will work with the leadership team
at Bako to help further the mission of high quality and service that both organizations have always valued.
“We are excited to partner with StrataDx in providing the highest quality clinical laboratory and pathology services to our respective customers,”
stated Ted Hull, CEO, Bako Diagnostics. “Bako will continue to focus on serving our customers in the podiatric market while benefitting from our
affiliation with one of the top dermatopathology and oral pathology labs in the country.”
ABOUT BAKO DIAGNOSTICS
Bako Diagnostics is a leading provider of diagnostic and therapeutic services for the Podiatric Medical Community with a unique focus on pathology of the lower extremity.
Bako’s comprehensive testing menu includes ENFD Analysis, Mass Spectrometry, rapid identification of bacteria from culture specimens, and Molecular Genetics for the detection
and identification of micro-organisms and as a diagnostic aid in certain pathologic diagnoses. Bako’s in-network services are available through its more than 250 million covered
lives, including all five national health plans and fully compliant patient-friendly billing policies. Over the past nine years, Bako has evolved into one of the podiatric profession’s
principal sources of educational sponsorship. For more information, visit bakodx.com.
StrataDx is a national diagnostic laboratory located in Lexington, Massachusetts dedicated to providing best-in-class pathology services to save lives. Led by dermatopathology experts,
StrataDx provides advanced diagnostics for a wide range of skin conditions including melanocytic and soft tissue lesions, dermatoses, and lymphomas. Board-certified oral pathologists
represent decades of expertise across a wide range of clinical specialties. StrataDx is considered a leader in testing for the dermatology market. For more information, visit stratadx.com.
Learn more about Bako Diagnostics and why we are excited to partner with them!